Drugs / Unasyn
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | UNASYN | — | 1986-12-31 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04198129 | Oct 2020 → Jan 2022 | infectious disease | The University of Texas Health Science Center, Houston | Terminated | No outcome recorded Stop: Enrollment |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00760006 Comparator | May 2008 → Aug 2015 | cleft palate | Joseph Losee | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Unasyn | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00760006 ↗ |